Rocket Pharmaceuticals, Inc. (RCKT)
3.45
-0.06
(-1.71%)
USD |
NASDAQ |
Jan 02, 12:21
Rocket Pharmaceuticals Total Liabilities (Quarterly): 54.36M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Merck & Co., Inc. | 77.64B |
| Avalo Therapeutics, Inc. | 33.55M |
| Artiva Biotherapeutics, Inc. | 19.64M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.03M |
| Shareholders Equity (Quarterly) | 313.67M |
| Debt to Equity Ratio | 0.0798 |
| Current Ratio | 7.304 |
| Net Debt Paydown Yield | 0.04% |